Morales J M, Andres A, Prieto C, Ruilope L M, Alcazar J M, Oliet A, Praga M, Rodicio J L
Department of Nephrology, Hospital 1 de Octubre, Madrid, Spain.
Transplant Proc. 1987 Oct;19(5):4005-7.
We reviewed the evolution of FENa in the EPP (first 4 weeks) in a group of CyA-treated patients as well as Aza-treated patients who did not present with acute rejection during this period of time. The CyA-treated patients showed lower values of FENa than did Aza-treated patients. Values of FENa below 1% were found in 51% of CyA- and 0% Aza-treated patients (P less than .01) before RFR. The finding of low FENa values was accompanied by more prolonged oliguric and RFR phases. Furthermore, the lower the level of FENa, the higher the prolongation of renal failure. We concluded that FENa values could probably be an index of CyA nephrotoxicity in the EPP.
我们回顾了一组接受环孢素(CyA)治疗的患者以及在此期间未发生急性排斥反应的接受硫唑嘌呤(Aza)治疗的患者在移植后早期阶段(前4周)尿钠排泄分数(FENa)的变化情况。接受CyA治疗的患者FENa值低于接受Aza治疗的患者。在进行肾替代治疗(RFR)前,51%接受CyA治疗的患者FENa值低于1%,而接受Aza治疗的患者中这一比例为0%(P<0.01)。FENa值较低与少尿期和RFR期延长有关。此外,FENa水平越低,肾衰竭持续时间越长。我们得出结论,FENa值可能是移植后早期阶段CyA肾毒性的一个指标。